A Second-Generation (44-Channel) Suprachoroidal Retinal Prosthesis: A Single-Arm Clinical Trial of Feasibility
To assess the feasibility of a second-generation (44-channel) suprachoroidal retinal prosthesis for provision of functional vision in recipients with end-stage retinitis pigmentosa (RP) over 2.7 years. Prospective, single-arm, unmasked interventional clinical trial. Four participants, with advanced...
Saved in:
| Published in | Ophthalmology science (Online) Vol. 5; no. 1; p. 100525 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Netherlands
Elsevier Inc
01.01.2025
Elsevier |
| Subjects | |
| Online Access | Get full text |
| ISSN | 2666-9145 2666-9145 |
| DOI | 10.1016/j.xops.2024.100525 |
Cover
Loading…
| Abstract | To assess the feasibility of a second-generation (44-channel) suprachoroidal retinal prosthesis for provision of functional vision in recipients with end-stage retinitis pigmentosa (RP) over 2.7 years.
Prospective, single-arm, unmasked interventional clinical trial.
Four participants, with advanced RP and bare-light perception vision.
The 44-channel suprachoroidal retinal prosthesis was implanted in the worse-seeing eye. Device stability, functionality, and adverse events were investigated at approximately 12-week intervals up to 140 weeks (2.7 years) postdevice activation.
Serious adverse event (SAE) reporting, visual response outcomes, functional vision outcomes, and quality-of-life outcomes.
All 4 participants (aged 39–66 years, 3 males) were successfully implanted in 2018, and there were no device-related SAEs over the duration of the study. A mild postoperative subretinal hemorrhage was detected in 2 recipients, which cleared spontaneously within 2 weeks. OCT confirmed device stability and position under the macula. Improvements in localization abilities were demonstrated for all 4 participants in screen-based, tabletop, and orientation and mobility tasks. In addition, 3 of 4 participants recorded improvements in motion discrimination and 2 of 4 participants recorded substantial improvements in spatial discrimination and identification of tabletop objects. Participants reported their unsupervised use of the device included exploring new environments, detecting people, and safely navigating around obstacles. A positive effect of the implant on participants’ daily lives in their local environments was confirmed by an orientation and mobility assessor and participant self-report. Emotional well-being was not impacted by device implantation or usage.
The completed clinical study demonstrates that the suprachoroidal prosthesis raises no safety concerns and provides improvements in functional vision, activities of daily living, and observer-rated quality of life.
Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article. |
|---|---|
| AbstractList | Purpose: To assess the feasibility of a second-generation (44-channel) suprachoroidal retinal prosthesis for provision of functional vision in recipients with end-stage retinitis pigmentosa (RP) over 2.7 years. Design: Prospective, single-arm, unmasked interventional clinical trial. Participants: Four participants, with advanced RP and bare-light perception vision. Methods: The 44-channel suprachoroidal retinal prosthesis was implanted in the worse-seeing eye. Device stability, functionality, and adverse events were investigated at approximately 12-week intervals up to 140 weeks (2.7 years) postdevice activation. Main Outcome Measures: Serious adverse event (SAE) reporting, visual response outcomes, functional vision outcomes, and quality-of-life outcomes. Results: All 4 participants (aged 39–66 years, 3 males) were successfully implanted in 2018, and there were no device-related SAEs over the duration of the study. A mild postoperative subretinal hemorrhage was detected in 2 recipients, which cleared spontaneously within 2 weeks. OCT confirmed device stability and position under the macula. Improvements in localization abilities were demonstrated for all 4 participants in screen-based, tabletop, and orientation and mobility tasks. In addition, 3 of 4 participants recorded improvements in motion discrimination and 2 of 4 participants recorded substantial improvements in spatial discrimination and identification of tabletop objects. Participants reported their unsupervised use of the device included exploring new environments, detecting people, and safely navigating around obstacles. A positive effect of the implant on participants’ daily lives in their local environments was confirmed by an orientation and mobility assessor and participant self-report. Emotional well-being was not impacted by device implantation or usage. Conclusions: The completed clinical study demonstrates that the suprachoroidal prosthesis raises no safety concerns and provides improvements in functional vision, activities of daily living, and observer-rated quality of life. Financial Disclosure(s): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article. PurposeTo assess the feasibility of a second-generation (44-channel) suprachoroidal retinal prosthesis for provision of functional vision in recipients with end-stage retinitis pigmentosa (RP) over 2.7 years. DesignProspective, single-arm, unmasked interventional clinical trial. ParticipantsFour participants, with advanced RP and bare-light perception vision. MethodsThe 44-channel suprachoroidal retinal prosthesis was implanted in the worse-seeing eye. Device stability, functionality, and adverse events were investigated at approximately 12-week intervals up to 140 weeks (2.7 years) postdevice activation. Main Outcome MeasuresSerious adverse event (SAE) reporting, visual response outcomes, functional vision outcomes, and quality-of-life outcomes. ResultsAll 4 participants (aged 39–66 years, 3 males) were successfully implanted in 2018, and there were no device-related SAEs over the duration of the study. A mild postoperative subretinal hemorrhage was detected in 2 recipients, which cleared spontaneously within 2 weeks. OCT confirmed device stability and position under the macula. Improvements in localization abilities were demonstrated for all 4 participants in screen-based, tabletop, and orientation and mobility tasks. In addition, 3 of 4 participants recorded improvements in motion discrimination and 2 of 4 participants recorded substantial improvements in spatial discrimination and identification of tabletop objects. Participants reported their unsupervised use of the device included exploring new environments, detecting people, and safely navigating around obstacles. A positive effect of the implant on participants’ daily lives in their local environments was confirmed by an orientation and mobility assessor and participant self-report. Emotional well-being was not impacted by device implantation or usage. ConclusionsThe completed clinical study demonstrates that the suprachoroidal prosthesis raises no safety concerns and provides improvements in functional vision, activities of daily living, and observer-rated quality of life. Financial Disclosure(s)Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article. To assess the feasibility of a second-generation (44-channel) suprachoroidal retinal prosthesis for provision of functional vision in recipients with end-stage retinitis pigmentosa (RP) over 2.7 years. Prospective, single-arm, unmasked interventional clinical trial. Four participants, with advanced RP and bare-light perception vision. The 44-channel suprachoroidal retinal prosthesis was implanted in the worse-seeing eye. Device stability, functionality, and adverse events were investigated at approximately 12-week intervals up to 140 weeks (2.7 years) postdevice activation. Serious adverse event (SAE) reporting, visual response outcomes, functional vision outcomes, and quality-of-life outcomes. All 4 participants (aged 39–66 years, 3 males) were successfully implanted in 2018, and there were no device-related SAEs over the duration of the study. A mild postoperative subretinal hemorrhage was detected in 2 recipients, which cleared spontaneously within 2 weeks. OCT confirmed device stability and position under the macula. Improvements in localization abilities were demonstrated for all 4 participants in screen-based, tabletop, and orientation and mobility tasks. In addition, 3 of 4 participants recorded improvements in motion discrimination and 2 of 4 participants recorded substantial improvements in spatial discrimination and identification of tabletop objects. Participants reported their unsupervised use of the device included exploring new environments, detecting people, and safely navigating around obstacles. A positive effect of the implant on participants’ daily lives in their local environments was confirmed by an orientation and mobility assessor and participant self-report. Emotional well-being was not impacted by device implantation or usage. The completed clinical study demonstrates that the suprachoroidal prosthesis raises no safety concerns and provides improvements in functional vision, activities of daily living, and observer-rated quality of life. Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article. To assess the feasibility of a second-generation (44-channel) suprachoroidal retinal prosthesis for provision of functional vision in recipients with end-stage retinitis pigmentosa (RP) over 2.7 years.PurposeTo assess the feasibility of a second-generation (44-channel) suprachoroidal retinal prosthesis for provision of functional vision in recipients with end-stage retinitis pigmentosa (RP) over 2.7 years.Prospective, single-arm, unmasked interventional clinical trial.DesignProspective, single-arm, unmasked interventional clinical trial.Four participants, with advanced RP and bare-light perception vision.ParticipantsFour participants, with advanced RP and bare-light perception vision.The 44-channel suprachoroidal retinal prosthesis was implanted in the worse-seeing eye. Device stability, functionality, and adverse events were investigated at approximately 12-week intervals up to 140 weeks (2.7 years) postdevice activation.MethodsThe 44-channel suprachoroidal retinal prosthesis was implanted in the worse-seeing eye. Device stability, functionality, and adverse events were investigated at approximately 12-week intervals up to 140 weeks (2.7 years) postdevice activation.Serious adverse event (SAE) reporting, visual response outcomes, functional vision outcomes, and quality-of-life outcomes.Main Outcome MeasuresSerious adverse event (SAE) reporting, visual response outcomes, functional vision outcomes, and quality-of-life outcomes.All 4 participants (aged 39-66 years, 3 males) were successfully implanted in 2018, and there were no device-related SAEs over the duration of the study. A mild postoperative subretinal hemorrhage was detected in 2 recipients, which cleared spontaneously within 2 weeks. OCT confirmed device stability and position under the macula. Improvements in localization abilities were demonstrated for all 4 participants in screen-based, tabletop, and orientation and mobility tasks. In addition, 3 of 4 participants recorded improvements in motion discrimination and 2 of 4 participants recorded substantial improvements in spatial discrimination and identification of tabletop objects. Participants reported their unsupervised use of the device included exploring new environments, detecting people, and safely navigating around obstacles. A positive effect of the implant on participants' daily lives in their local environments was confirmed by an orientation and mobility assessor and participant self-report. Emotional well-being was not impacted by device implantation or usage.ResultsAll 4 participants (aged 39-66 years, 3 males) were successfully implanted in 2018, and there were no device-related SAEs over the duration of the study. A mild postoperative subretinal hemorrhage was detected in 2 recipients, which cleared spontaneously within 2 weeks. OCT confirmed device stability and position under the macula. Improvements in localization abilities were demonstrated for all 4 participants in screen-based, tabletop, and orientation and mobility tasks. In addition, 3 of 4 participants recorded improvements in motion discrimination and 2 of 4 participants recorded substantial improvements in spatial discrimination and identification of tabletop objects. Participants reported their unsupervised use of the device included exploring new environments, detecting people, and safely navigating around obstacles. A positive effect of the implant on participants' daily lives in their local environments was confirmed by an orientation and mobility assessor and participant self-report. Emotional well-being was not impacted by device implantation or usage.The completed clinical study demonstrates that the suprachoroidal prosthesis raises no safety concerns and provides improvements in functional vision, activities of daily living, and observer-rated quality of life.ConclusionsThe completed clinical study demonstrates that the suprachoroidal prosthesis raises no safety concerns and provides improvements in functional vision, activities of daily living, and observer-rated quality of life.Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.Financial DisclosuresProprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article. |
| ArticleNumber | 100525 |
| Author | Titchener, Samuel A. Villalobos, Joel Kvansakul, Jessica Kentler, William G. Walker, Janine G. Allen, Penelope J. McDermott, Hugh J. Kolic, Maria Young, Kiera A. Barnes, Nick Luu, Chi D. Thien, Patrick C. McGuinness, Myra B. Blamey, Peter J. Nayagam, David A.X. Baglin, Elizabeth K. McGowan, Ceara Shivdasani, Mohit N. Burns, Owen Seligman, Peter M. Abbott, Carla J. Yeoh, Jonathan Shepherd, Robert K. Millard, Rodney E. Johnson, Dean Karapanos, Lewis Sinclair, Nicholas C. Ayton, Lauren N. Petoe, Matthew A. Briggs, Robert J. Williams, Chris E. Epp, Stephanie B. |
| Author_xml | – sequence: 1 givenname: Matthew A. orcidid: 0000-0002-1865-3566 surname: Petoe fullname: Petoe, Matthew A. organization: Bionics Institute, Melbourne, Victoria, Australia – sequence: 2 givenname: Carla J. orcidid: 0000-0002-1432-8977 surname: Abbott fullname: Abbott, Carla J. organization: Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia – sequence: 3 givenname: Samuel A. orcidid: 0000-0001-8312-2924 surname: Titchener fullname: Titchener, Samuel A. organization: Bionics Institute, Melbourne, Victoria, Australia – sequence: 4 givenname: Maria surname: Kolic fullname: Kolic, Maria organization: Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia – sequence: 5 givenname: William G. surname: Kentler fullname: Kentler, William G. organization: Department of Biomedical Engineering, University of Melbourne, Melbourne, Victoria, Australia – sequence: 6 givenname: David A.X. orcidid: 0000-0002-4380-6640 surname: Nayagam fullname: Nayagam, David A.X. organization: Bionics Institute, Melbourne, Victoria, Australia – sequence: 7 givenname: Elizabeth K. orcidid: 0000-0002-1754-9310 surname: Baglin fullname: Baglin, Elizabeth K. organization: Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia – sequence: 8 givenname: Jessica surname: Kvansakul fullname: Kvansakul, Jessica organization: Bionics Institute, Melbourne, Victoria, Australia – sequence: 9 givenname: Nick surname: Barnes fullname: Barnes, Nick organization: Research School of Engineering, Australian National University, Canberra, Australian Capital Territory, Australia – sequence: 10 givenname: Janine G. surname: Walker fullname: Walker, Janine G. organization: Research School of Engineering, Australian National University, Canberra, Australian Capital Territory, Australia – sequence: 11 givenname: Lewis orcidid: 0000-0003-4115-7840 surname: Karapanos fullname: Karapanos, Lewis organization: Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia – sequence: 12 givenname: Myra B. orcidid: 0000-0002-5422-040X surname: McGuinness fullname: McGuinness, Myra B. organization: Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia – sequence: 13 givenname: Lauren N. orcidid: 0000-0001-9907-084X surname: Ayton fullname: Ayton, Lauren N. organization: Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia – sequence: 14 givenname: Chi D. surname: Luu fullname: Luu, Chi D. organization: Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia – sequence: 15 givenname: Penelope J. orcidid: 0000-0001-5916-1253 surname: Allen fullname: Allen, Penelope J. email: pjallen@melbourneretina.com.au organization: Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia – sequence: 16 givenname: Peter J. surname: Blamey fullname: Blamey, Peter J. – sequence: 17 givenname: Robert J. surname: Briggs fullname: Briggs, Robert J. – sequence: 18 givenname: Owen surname: Burns fullname: Burns, Owen – sequence: 19 givenname: Stephanie B. surname: Epp fullname: Epp, Stephanie B. – sequence: 20 givenname: Dean surname: Johnson fullname: Johnson, Dean – sequence: 21 givenname: Hugh J. surname: McDermott fullname: McDermott, Hugh J. – sequence: 22 givenname: Ceara surname: McGowan fullname: McGowan, Ceara – sequence: 23 givenname: Rodney E. surname: Millard fullname: Millard, Rodney E. – sequence: 24 givenname: Peter M. surname: Seligman fullname: Seligman, Peter M. – sequence: 25 givenname: Robert K. surname: Shepherd fullname: Shepherd, Robert K. – sequence: 26 givenname: Mohit N. surname: Shivdasani fullname: Shivdasani, Mohit N. – sequence: 27 givenname: Nicholas C. surname: Sinclair fullname: Sinclair, Nicholas C. – sequence: 28 givenname: Patrick C. surname: Thien fullname: Thien, Patrick C. – sequence: 29 givenname: Joel surname: Villalobos fullname: Villalobos, Joel – sequence: 30 givenname: Chris E. surname: Williams fullname: Williams, Chris E. – sequence: 31 givenname: Jonathan surname: Yeoh fullname: Yeoh, Jonathan – sequence: 32 givenname: Kiera A. surname: Young fullname: Young, Kiera A. |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39328823$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkltvEzEQhVeoiJbSP8AD2sfysMG3vaRCoCiipVIlECnPlteeTSY4dmpvKvLv8TahaitRXmxrfM4Zy_O9zg6cd5BlbykZUUKrD8vRb7-OI0aYSAVSsvJFdsSqqirGVJQHD86H2UmMS0IIKylngr7KDvmYs6Zh_Chzk3wG2jtTXICDoHr0Lj8VopgulHNg3-ezzToovfDBo1E2_wE9urR_Dz72C4gYz_KUgW5uoZiEVT616FAnxXXAtPouPwcVsUWL_fZN9rJTNsLJfj_Ofp5_uZ5-La6-XVxOJ1eFrljTFw3nhHRlqwnltRFKjyvaim7c6ppyYohgZaNZacpaCF3V0HZl04q2UV0JoAzhx9nlLtd4tZTrgCsVttIrlHcFH-ZShR61BckVI4oqSgxrRF22Yy1qUxte1awjwCFlfd5lrTftCowG1wdlH4U-vnG4kHN_KykVrCKCpoTTfULwNxuIvVxh1GCtcuA3UXJKiSC84SxJ3z1sdt_l78SSgO0EOg0gBujuJZTIgQy5lAMZciBD7shIpuaJSWN_N-v0YLTPWz_urJDGdYsQZNQIToPBALpP_4nP2z89ses9H79gC3HpNyHRFCWVkUkiZwO1A7RMJGArWqeAs38H_K_7Hz-l-3Y |
| CitedBy_id | crossref_primary_10_3389_fcell_2024_1422764 crossref_primary_10_1111_ceo_14502 crossref_primary_10_1167_tvst_13_12_28 |
| Cites_doi | 10.1016/j.visres.2015.03.001 10.1016/j.clinph.2019.11.029 10.1167/tvst.10.10.7 10.1167/iovs.14-14396 10.1167/iovs.14-14731 10.1111/ceo.12287 10.1167/tvst.9.12.27 10.1167/iovs.13-12657 10.1111/cxo.12444 10.1111/ceo.12812 10.3389/fnins.2017.00445 10.1186/s12886-016-0225-1 10.1016/j.exer.2016.03.018 10.1016/j.preteyeres.2016.05.002 10.1167/iovs.16-20367 10.1167/tvst.9.13.31 10.1371/journal.pone.0230713 10.1007/s00417-015-3253-2 10.1016/j.preteyeres.2017.10.004 10.1016/j.preteyeres.2013.01.002 10.1073/pnas.89.20.9666 10.1167/tvst.9.8.25 10.1046/j.1525-1497.2001.016009606.x 10.1167/iovs.14-14732 10.1016/j.ajo.2007.01.027 10.1111/cxo.12359 10.18240/ijo.2021.02.20 10.1371/journal.pone.0115239 10.1111/cxo.12242 10.1167/tvst.10.10.12 10.1167/iovs.16-21041 10.1371/journal.pone.0134369 10.1016/j.ophtha.2017.09.019 10.1167/tvst.12.3.20 10.1111/ceo.13950 10.1167/iovs.09-3512 10.1167/tvst.11.6.12 10.1016/j.ophtha.2016.06.049 10.1088/1741-2560/13/3/036013 10.1167/iovs.04-1389 10.1080/01621459.1988.10478715 10.1136/bjo.2010.179622 10.1001/2013.jamaophthalmol.221 10.1167/tvst.11.9.4 10.1001/jamaophthalmol.2019.1476 |
| ContentType | Journal Article |
| Contributor | Epp, Stephanie B Sinclair, Nicholas C Burns, Owen Villalobos, Joel Millard, Rodney E Seligman, Peter M Yeoh, Jonathan Shepherd, Robert K Briggs, Robert J Johnson, Dean Williams, Chris E Young, Kiera A Thien, Patrick C Shivdasani, Mohit N McDermott, Hugh J Blamey, Peter J McGowan, Ceara |
| Contributor_xml | – sequence: 1 givenname: Peter J surname: Blamey fullname: Blamey, Peter J – sequence: 2 givenname: Robert J surname: Briggs fullname: Briggs, Robert J – sequence: 3 givenname: Owen surname: Burns fullname: Burns, Owen – sequence: 4 givenname: Stephanie B surname: Epp fullname: Epp, Stephanie B – sequence: 5 givenname: Dean surname: Johnson fullname: Johnson, Dean – sequence: 6 givenname: Hugh J surname: McDermott fullname: McDermott, Hugh J – sequence: 7 givenname: Ceara surname: McGowan fullname: McGowan, Ceara – sequence: 8 givenname: Rodney E surname: Millard fullname: Millard, Rodney E – sequence: 9 givenname: Peter M surname: Seligman fullname: Seligman, Peter M – sequence: 10 givenname: Robert K surname: Shepherd fullname: Shepherd, Robert K – sequence: 11 givenname: Mohit N surname: Shivdasani fullname: Shivdasani, Mohit N – sequence: 12 givenname: Nicholas C surname: Sinclair fullname: Sinclair, Nicholas C – sequence: 13 givenname: Patrick C surname: Thien fullname: Thien, Patrick C – sequence: 14 givenname: Joel surname: Villalobos fullname: Villalobos, Joel – sequence: 15 givenname: Chris E surname: Williams fullname: Williams, Chris E – sequence: 16 givenname: Jonathan surname: Yeoh fullname: Yeoh, Jonathan – sequence: 17 givenname: Kiera A surname: Young fullname: Young, Kiera A |
| Copyright | 2024 American Academy of Ophthalmology American Academy of Ophthalmology 2024 by the American Academy of Ophthalmology. 2024 by the American Academy of Ophthalmology. 2024 American Academy of Ophthalmology |
| Copyright_xml | – notice: 2024 American Academy of Ophthalmology – notice: American Academy of Ophthalmology – notice: 2024 by the American Academy of Ophthalmology. – notice: 2024 by the American Academy of Ophthalmology. 2024 American Academy of Ophthalmology |
| CorporateAuthor | Bionics Institute and Centre for Eye Research Australia Retinal Prosthesis Consortium |
| CorporateAuthor_xml | – name: Bionics Institute and Centre for Eye Research Australia Retinal Prosthesis Consortium |
| DBID | 6I. AAFTH AAYXX CITATION NPM 7X8 5PM DOA |
| DOI | 10.1016/j.xops.2024.100525 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Open Access Full Text url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2666-9145 |
| EndPage | 100525 |
| ExternalDocumentID | oai_doaj_org_article_3a20a1a10d28475b9c47d7d3672f0e3e PMC11426041 39328823 10_1016_j_xops_2024_100525 S2666914524000617 1_s2_0_S2666914524000617 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: Victorian Government funderid: https://doi.org/10.13039/501100004752 |
| GroupedDBID | .1- .FO 0R~ AAEDW AALRI AAXUO AAYWO ACVFH ADCNI ADVLN AEUPX AFJKZ AFPUW AFRHN AIGII AITUG AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ APXCP EBS FDB GROUPED_DOAJ M~E OK1 ROL RPM Z5R AAHOK 6I. AAFTH AAYXX CITATION NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c628t-83300f5bc0137d4ac961b4f9bc7130d04258c25d5744c67ebf58b4b8af5eead03 |
| IEDL.DBID | DOA |
| ISSN | 2666-9145 |
| IngestDate | Wed Aug 27 01:11:52 EDT 2025 Thu Aug 21 18:31:21 EDT 2025 Thu Jul 10 23:55:12 EDT 2025 Mon Jul 21 05:58:35 EDT 2025 Tue Jul 01 03:50:43 EDT 2025 Thu Apr 24 22:50:41 EDT 2025 Sat Jan 18 16:09:34 EST 2025 Mon Feb 24 20:18:34 EST 2025 Tue Aug 26 16:33:12 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | COVID-19 Bionic eye EWB Activities of daily living Retinitis pigmentosa cpd FLORA SAE IVI-VLV Functional vision RP Suprachoroidal retinal prosthesis impact of vision impairment–very low vision emotional well-being Functional Low-Vision Observer-Rated Assessment coronavirus disease 2019 serious adverse event cycles-per-degree |
| Language | English |
| License | This is an open access article under the CC BY-NC-ND license. 2024 by the American Academy of Ophthalmology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c628t-83300f5bc0137d4ac961b4f9bc7130d04258c25d5744c67ebf58b4b8af5eead03 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-1754-9310 0000-0001-8312-2924 0000-0002-1432-8977 0000-0003-4115-7840 0000-0002-4380-6640 0000-0002-1865-3566 0000-0001-9907-084X 0000-0002-5422-040X 0000-0001-5916-1253 |
| OpenAccessLink | https://doaj.org/article/3a20a1a10d28475b9c47d7d3672f0e3e |
| PMID | 39328823 |
| PQID | 3110403832 |
| PQPubID | 23479 |
| PageCount | 1 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_3a20a1a10d28475b9c47d7d3672f0e3e pubmedcentral_primary_oai_pubmedcentral_nih_gov_11426041 proquest_miscellaneous_3110403832 pubmed_primary_39328823 crossref_primary_10_1016_j_xops_2024_100525 crossref_citationtrail_10_1016_j_xops_2024_100525 elsevier_sciencedirect_doi_10_1016_j_xops_2024_100525 elsevier_clinicalkeyesjournals_1_s2_0_S2666914524000617 elsevier_clinicalkey_doi_10_1016_j_xops_2024_100525 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2025-01-01 |
| PublicationDateYYYYMMDD | 2025-01-01 |
| PublicationDate_xml | – month: 01 year: 2025 text: 2025-01-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | Ophthalmology science (Online) |
| PublicationTitleAlternate | Ophthalmol Sci |
| PublicationYear | 2025 |
| Publisher | Elsevier Inc Elsevier |
| Publisher_xml | – name: Elsevier Inc – name: Elsevier |
| References | Misajon, Hawthorne, Richardson (bib49) 2005; 46 da Cruz, Dorn, Humayun (bib44) 2016; 123 Ostad-Ahmadi, Daemi, Modabberi (bib3) 2021; 14 Muqit, Hubschman, Picaud (bib33) 2020; 15 Finger, McSweeney, Deverell (bib23) 2014; 55 Edwards, Cottriall, Xue (bib5) 2018; 125 Petoe, Titchener, Kolic (bib11) 2021; 10 Luo, Zhong, Merlini (bib43) 2014; 55 Ayton, Barnes, Dagnelie (bib2) 2020; 131 Ahuja, Dorn, Caspi (bib38) 2011; 95 Titchener, Nayagam, Kvansakul (bib31) 2022; 11 Ahuja, Behrend (bib20) 2013; 36 Stingl, Schippert, Bartz-Schmidt (bib7) 2017; 11 Finger, Tellis, Crewe (bib25) 2014; 55 Kroenke, Spitzer, Williams (bib26) 2001; 16 Duncan, Richards, Arditi (bib50) 2017; 100 Barnes, Scott, Lieby (bib15) 2016; 13 Ghodasra, Chen, Arevalo (bib32) 2016; 16 Jones, Pfeiffer, Ferrell (bib37) 2016; 150 Dagnelie, Christopher, Arditi (bib48) 2017; 45 Nayagam, Thien, Abbott (bib16) 2017; 58 Fujikado, Kamei, Sakaguchi (bib35) 2016; 57 Dacey, Petersen (bib14) 1992; 89 Geruschat, Richards, Arditi (bib46) 2016; 99 Allen (bib8) 2021; 49 Ayton, Blamey, Guymer (bib10) 2014; 9 Geruschat, Flax, Tanna (bib24) 2015; 98 Stingl, Bartz-Schmidt, Besch (bib6) 2015; 111 Saunders, Williams, Heriot (bib17) 2014; 42 Ayton, Apollo, Varsamidis (bib13) 2014; 55 Titchener, Goossens, Kvansakul (bib41) 2023; 12 Wittkowski (bib28) 1988; 83 Dorn, Ahuja, Caspi (bib39) 2013; 131 Conover (bib29) 1998 Yue, Weiland, Roska (bib36) 2016; 53 Titchener, Kvansakul, Shivdasani (bib40) 2020; 9 Garcia, Petrini, Rubin (bib45) 2015; 10 Abbott, Baglin, Kolic (bib27) 2022; 11 Dias, Joo, Kemp (bib1) 2018; 63 Ayton, Rizzo, Bailey (bib19) 2020; 9 Shivdasani, Sinclair, Dimitrov (bib18) 2014; 55 Schaffrath, Schellhase, Walter (bib34) 2019; 137 Bach, Wilke, Wilhelm (bib22) 2010; 51 Petoe, McCarthy, Shivdasani (bib21) 2017; 58 Yanai, Weiland, Mahadevappa (bib4) 2007; 143 Yanovitch, Raz-Prag, Hanein (bib9) 2022 Karapanos, Abbott, Ayton (bib12) 2021; 10 Holm (bib30) 1979; 6 Endo, Kanda, Hirota (bib42) 2016; 254 Kartha, Sadeghi, Barry (bib47) 2020; 9 Petoe (10.1016/j.xops.2024.100525_bib21) 2017; 58 Dorn (10.1016/j.xops.2024.100525_bib39) 2013; 131 Ayton (10.1016/j.xops.2024.100525_bib10) 2014; 9 Ayton (10.1016/j.xops.2024.100525_bib19) 2020; 9 Kartha (10.1016/j.xops.2024.100525_bib47) 2020; 9 Luo (10.1016/j.xops.2024.100525_bib43) 2014; 55 Duncan (10.1016/j.xops.2024.100525_bib50) 2017; 100 Fujikado (10.1016/j.xops.2024.100525_bib35) 2016; 57 Dias (10.1016/j.xops.2024.100525_bib1) 2018; 63 Petoe (10.1016/j.xops.2024.100525_bib11) 2021; 10 Dacey (10.1016/j.xops.2024.100525_bib14) 1992; 89 Karapanos (10.1016/j.xops.2024.100525_bib12) 2021; 10 Bach (10.1016/j.xops.2024.100525_bib22) 2010; 51 Schaffrath (10.1016/j.xops.2024.100525_bib34) 2019; 137 Stingl (10.1016/j.xops.2024.100525_bib6) 2015; 111 Shivdasani (10.1016/j.xops.2024.100525_bib18) 2014; 55 Ayton (10.1016/j.xops.2024.100525_bib13) 2014; 55 Endo (10.1016/j.xops.2024.100525_bib42) 2016; 254 Nayagam (10.1016/j.xops.2024.100525_bib16) 2017; 58 Dagnelie (10.1016/j.xops.2024.100525_bib48) 2017; 45 Kroenke (10.1016/j.xops.2024.100525_bib26) 2001; 16 Finger (10.1016/j.xops.2024.100525_bib23) 2014; 55 Saunders (10.1016/j.xops.2024.100525_bib17) 2014; 42 Yue (10.1016/j.xops.2024.100525_bib36) 2016; 53 Garcia (10.1016/j.xops.2024.100525_bib45) 2015; 10 Misajon (10.1016/j.xops.2024.100525_bib49) 2005; 46 da Cruz (10.1016/j.xops.2024.100525_bib44) 2016; 123 Titchener (10.1016/j.xops.2024.100525_bib40) 2020; 9 Yanai (10.1016/j.xops.2024.100525_bib4) 2007; 143 Finger (10.1016/j.xops.2024.100525_bib25) 2014; 55 Ahuja (10.1016/j.xops.2024.100525_bib38) 2011; 95 Wittkowski (10.1016/j.xops.2024.100525_bib28) 1988; 83 Jones (10.1016/j.xops.2024.100525_bib37) 2016; 150 Stingl (10.1016/j.xops.2024.100525_bib7) 2017; 11 Ghodasra (10.1016/j.xops.2024.100525_bib32) 2016; 16 Abbott (10.1016/j.xops.2024.100525_bib27) 2022; 11 Titchener (10.1016/j.xops.2024.100525_bib41) 2023; 12 Yanovitch (10.1016/j.xops.2024.100525_bib9) 2022 Conover (10.1016/j.xops.2024.100525_bib29) 1998 Ostad-Ahmadi (10.1016/j.xops.2024.100525_bib3) 2021; 14 Geruschat (10.1016/j.xops.2024.100525_bib24) 2015; 98 Barnes (10.1016/j.xops.2024.100525_bib15) 2016; 13 Muqit (10.1016/j.xops.2024.100525_bib33) 2020; 15 Geruschat (10.1016/j.xops.2024.100525_bib46) 2016; 99 Allen (10.1016/j.xops.2024.100525_bib8) 2021; 49 Titchener (10.1016/j.xops.2024.100525_bib31) 2022; 11 Edwards (10.1016/j.xops.2024.100525_bib5) 2018; 125 Ahuja (10.1016/j.xops.2024.100525_bib20) 2013; 36 Ayton (10.1016/j.xops.2024.100525_bib2) 2020; 131 Holm (10.1016/j.xops.2024.100525_bib30) 1979; 6 |
| References_xml | – volume: 46 start-page: 4007 year: 2005 end-page: 4015 ident: bib49 article-title: Vision and quality of life: the development of a utility measure publication-title: Invest Ophthalmol Vis Sci – volume: 100 start-page: 144 year: 2017 end-page: 150 ident: bib50 article-title: Improvements in vision-related quality of life in blind patients implanted with the Argus II Epiretinal Prosthesis publication-title: Clin Exp Optom – volume: 16 start-page: 52 year: 2016 ident: bib32 article-title: Worldwide Argus II implantation: recommendations to optimize patient outcomes publication-title: BMC Ophthalmol – volume: 58 start-page: 3231 year: 2017 end-page: 3239 ident: bib21 article-title: Determining the contribution of retinotopic discrimination to localization performance with a suprachoroidal retinal prosthesis publication-title: Invest Ophthalmol Vis Sci – volume: 143 start-page: 820 year: 2007 end-page: 827. e822 ident: bib4 article-title: Visual performance using a retinal prosthesis in three subjects with retinitis pigmentosa publication-title: Am J Ophthalmol – volume: 11 start-page: 4 year: 2022 ident: bib27 article-title: Interobserver agreement of electrode to retina distance measurements in a second-generation (44-channel) suprachoroidal retinal prosthesis publication-title: Transl Vis Sci Technol – volume: 10 start-page: 7 year: 2021 ident: bib12 article-title: Functional vision in the real-world environment with a second-generation (44-channel) suprachoroidal retinal prosthesis publication-title: Transl Vis Sci Technol – volume: 13 start-page: 15 year: 2016 ident: bib15 article-title: Vision function testing for a suprachoroidal retinal prosthesis: effects of image filtering publication-title: J Neural Eng – volume: 123 start-page: 2248 year: 2016 end-page: 2254 ident: bib44 article-title: Five-year safety and performance results from the Argus II retinal prosthesis system clinical trial publication-title: Ophthalmology – volume: 10 year: 2015 ident: bib45 article-title: Visual and non-visual navigation in blind patients with a retinal prosthesis publication-title: PLoS One – volume: 55 start-page: 6467 year: 2014 end-page: 6481 ident: bib18 article-title: Factors affecting perceptual thresholds in a suprachoroidal retinal prosthesis publication-title: Invest Ophthalmol Vis Sci – volume: 42 start-page: 665 year: 2014 end-page: 674 ident: bib17 article-title: Development of a surgical procedure for implantation of a prototype suprachoroidal retinal prosthesis publication-title: Clin Exp Ophthalmol – volume: 9 start-page: 25 year: 2020 ident: bib19 article-title: Harmonization of outcomes and vision endpoints in vision restoration trials: recommendations from the international HOVER taskforce publication-title: Transl Vis Sci Technol – volume: 55 start-page: 6150 year: 2014 end-page: 6158 ident: bib25 article-title: Developing the impact of vision impairment-very low vision (IVI-VLV) questionnaire as part of the LoVADA protocol publication-title: Invest Ophthalmol Vis Sci – year: 1998 ident: bib29 article-title: Practical nonparametric statistics – volume: 53 start-page: 21 year: 2016 end-page: 47 ident: bib36 article-title: Retinal stimulation strategies to restore vision: fundamentals and systems publication-title: Prog Retin Eye Res – volume: 125 start-page: 432 year: 2018 end-page: 443 ident: bib5 article-title: Assessment of the electronic retinal implant Alpha AMS in restoring vision to blind patients with end-stage retinitis pigmentosa publication-title: Ophthalmology – volume: 57 start-page: 6147 year: 2016 end-page: 6157 ident: bib35 article-title: One-year outcome of 49-channel suprachoroidal–transretinal stimulation prosthesis in patients with advanced retinitis pigmentosa publication-title: Invest Ophthalmol Vis Sci – volume: 11 start-page: 12 year: 2022 ident: bib31 article-title: A second-generation (44-channel) suprachoroidal retinal prosthesis: long-term observation of the electrode–tissue interface publication-title: Transl Vis Sci Technol – volume: 15 year: 2020 ident: bib33 article-title: PRIMA subretinal wireless photovoltaic microchip implantation in non-human primate and feline models publication-title: PLoS One – volume: 12 start-page: 20 year: 2023 ident: bib41 article-title: Estimating phosphene locations using eye movements of suprachoroidal retinal prosthesis users publication-title: Transl Vis Sci Technol – volume: 6 start-page: 65 year: 1979 end-page: 70 ident: bib30 article-title: A simple sequentially rejective multiple test procedure publication-title: Scand J Stat – volume: 55 start-page: 8458 year: 2014 end-page: 8466 ident: bib23 article-title: Developing an instrumental activities of daily living tool as part of the low vision assessment of daily activities protocol publication-title: Invest Ophthalmol Vis Sci – volume: 14 start-page: 310 year: 2021 end-page: 316 ident: bib3 article-title: Safety, effectiveness, and cost-effectiveness of Argus II in patients with retinitis pigmentosa: a systematic review publication-title: Int J Ophthalmol-Chi – volume: 10 start-page: 12 year: 2021 ident: bib11 article-title: A second-generation (44-channel) suprachoroidal retinal prosthesis: interim clinical trial results publication-title: Transl Vis Sci Technol – volume: 36 start-page: 1 year: 2013 end-page: 23 ident: bib20 article-title: The Argus™ II retinal prosthesis: factors affecting patient selection for implantation publication-title: Prog Retin Eye Res – volume: 131 start-page: 183 year: 2013 end-page: 189 ident: bib39 article-title: The detection of motion by blind subjects with the epiretinal 60-electrode (Argus II) retinal prosthesis publication-title: JAMA Ophthalmol – volume: 51 start-page: 1255 year: 2010 end-page: 1260 ident: bib22 article-title: Basic quantitative assessment of visual performance in patients with Very low vision publication-title: Invest Ophthalmol Vis Sci – volume: 58 start-page: 4204 year: 2017 ident: bib16 article-title: A pre-clinical model for safe retinal stimulation publication-title: Invest Ophthalmol Vis Sci – volume: 9 year: 2014 ident: bib10 article-title: First-in-human trial of a novel suprachoroidal retinal prosthesis publication-title: PLoS One – volume: 137 start-page: 896 year: 2019 end-page: 902 ident: bib34 article-title: One-year safety and performance assessment of the Argus II retinal prosthesis: a postapproval study publication-title: JAMA Ophthalmol – volume: 111 start-page: 149 year: 2015 end-page: 160 ident: bib6 article-title: Subretinal visual implant Alpha IMS – clinical trial interim report publication-title: Vis Res – volume: 150 start-page: 149 year: 2016 end-page: 165 ident: bib37 article-title: Retinal remodeling in human retinitis pigmentosa publication-title: Exp Eye Res – year: 2022 ident: bib9 article-title: A new high-resolution three-dimensional retinal implant: system design and preliminary human results publication-title: bioRxiv – volume: 63 start-page: 107 year: 2018 end-page: 131 ident: bib1 article-title: Molecular genetics and emerging therapies for retinitis pigmentosa: basic research and clinical perspectives publication-title: Prog Retin Eye Res – volume: 9 start-page: 27 year: 2020 ident: bib47 article-title: Prosthetic visual performance using a disparity-based distance-filtering system publication-title: Transl Vis Sci Technol – volume: 95 start-page: 539 year: 2011 end-page: 543 ident: bib38 article-title: Blind subjects implanted with the Argus II retinal prosthesis are able to improve performance in a spatial-motor task publication-title: Br J Ophthalmol – volume: 99 start-page: 227 year: 2016 end-page: 232 ident: bib46 article-title: An analysis of observer-rated functional vision in patients implanted with the Argus II Retinal Prosthesis System at three years publication-title: Clin Exp Optom – volume: 89 start-page: 9666 year: 1992 end-page: 9670 ident: bib14 article-title: Dendritic field size and morphology of midget and parasol ganglion cells of the human retina publication-title: Proc Natl Acad Sci USA – volume: 16 start-page: 606 year: 2001 end-page: 613 ident: bib26 article-title: The PHQ-9: validity of a brief depression severity measure publication-title: J Gen Intern Med – volume: 45 start-page: 152 year: 2017 end-page: 159 ident: bib48 article-title: Performance of real-world functional vision tasks by blind subjects improves after implantation with the Argus® II retinal prosthesis system publication-title: Clin Exp Ophthalmol – volume: 83 start-page: 1163 year: 1988 end-page: 1170 ident: bib28 article-title: Friedman-type statistics and consistent multiple comparisons for unbalanced designs with missing data publication-title: J Am Stat Assoc – volume: 11 start-page: 445 year: 2017 ident: bib7 article-title: Interim results of a multicenter trial with the new electronic subretinal implant Alpha AMS in 15 patients blind from inherited retinal degenerations publication-title: Front Neurosci – volume: 55 start-page: 1332 year: 2014 end-page: 1338 ident: bib13 article-title: Assessing residual visual function in severe vision loss publication-title: Invest Ophthalmol Vis Sci – volume: 55 start-page: 1834 year: 2014 ident: bib43 article-title: The use of Argus® II retinal prosthesis to identify common objects in blind subjects with outer retinal dystrophies publication-title: Invest Ophthalmol Vis Sci – volume: 49 start-page: 418 year: 2021 end-page: 429 ident: bib8 article-title: Retinal prostheses: where to from here? publication-title: Clin Exp Ophthalmol – volume: 131 start-page: 1383 year: 2020 end-page: 1398 ident: bib2 article-title: An update on retinal prostheses publication-title: Clin Neurophysiol – volume: 9 start-page: 31 year: 2020 ident: bib40 article-title: Oculomotor responses to dynamic stimuli in a 44-channel suprachoroidal retinal prosthesis publication-title: Transl Vis Sci Technol – volume: 98 start-page: 342 year: 2015 end-page: 347 ident: bib24 article-title: FLORA™: phase I development of a functional vision assessment for prosthetic vision users publication-title: Clin Exp Optom – volume: 254 start-page: 947 year: 2016 end-page: 956 ident: bib42 article-title: False reaching movements in localization test and effect of auditory feedback in simulated ultra-low vision subjects and patients with retinitis pigmentosa publication-title: Graefes Arch Clin Exp Ophthalmol – volume: 111 start-page: 149 year: 2015 ident: 10.1016/j.xops.2024.100525_bib6 article-title: Subretinal visual implant Alpha IMS – clinical trial interim report publication-title: Vis Res doi: 10.1016/j.visres.2015.03.001 – volume: 131 start-page: 1383 year: 2020 ident: 10.1016/j.xops.2024.100525_bib2 article-title: An update on retinal prostheses publication-title: Clin Neurophysiol doi: 10.1016/j.clinph.2019.11.029 – volume: 10 start-page: 7 year: 2021 ident: 10.1016/j.xops.2024.100525_bib12 article-title: Functional vision in the real-world environment with a second-generation (44-channel) suprachoroidal retinal prosthesis publication-title: Transl Vis Sci Technol doi: 10.1167/tvst.10.10.7 – volume: 55 start-page: 6467 year: 2014 ident: 10.1016/j.xops.2024.100525_bib18 article-title: Factors affecting perceptual thresholds in a suprachoroidal retinal prosthesis publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.14-14396 – volume: 55 start-page: 6150 year: 2014 ident: 10.1016/j.xops.2024.100525_bib25 article-title: Developing the impact of vision impairment-very low vision (IVI-VLV) questionnaire as part of the LoVADA protocol publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.14-14731 – volume: 42 start-page: 665 year: 2014 ident: 10.1016/j.xops.2024.100525_bib17 article-title: Development of a surgical procedure for implantation of a prototype suprachoroidal retinal prosthesis publication-title: Clin Exp Ophthalmol doi: 10.1111/ceo.12287 – volume: 9 start-page: 27 year: 2020 ident: 10.1016/j.xops.2024.100525_bib47 article-title: Prosthetic visual performance using a disparity-based distance-filtering system publication-title: Transl Vis Sci Technol doi: 10.1167/tvst.9.12.27 – volume: 55 start-page: 1332 year: 2014 ident: 10.1016/j.xops.2024.100525_bib13 article-title: Assessing residual visual function in severe vision loss publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.13-12657 – volume: 100 start-page: 144 year: 2017 ident: 10.1016/j.xops.2024.100525_bib50 article-title: Improvements in vision-related quality of life in blind patients implanted with the Argus II Epiretinal Prosthesis publication-title: Clin Exp Optom doi: 10.1111/cxo.12444 – volume: 45 start-page: 152 year: 2017 ident: 10.1016/j.xops.2024.100525_bib48 article-title: Performance of real-world functional vision tasks by blind subjects improves after implantation with the Argus® II retinal prosthesis system publication-title: Clin Exp Ophthalmol doi: 10.1111/ceo.12812 – volume: 11 start-page: 445 year: 2017 ident: 10.1016/j.xops.2024.100525_bib7 article-title: Interim results of a multicenter trial with the new electronic subretinal implant Alpha AMS in 15 patients blind from inherited retinal degenerations publication-title: Front Neurosci doi: 10.3389/fnins.2017.00445 – volume: 16 start-page: 52 year: 2016 ident: 10.1016/j.xops.2024.100525_bib32 article-title: Worldwide Argus II implantation: recommendations to optimize patient outcomes publication-title: BMC Ophthalmol doi: 10.1186/s12886-016-0225-1 – volume: 150 start-page: 149 year: 2016 ident: 10.1016/j.xops.2024.100525_bib37 article-title: Retinal remodeling in human retinitis pigmentosa publication-title: Exp Eye Res doi: 10.1016/j.exer.2016.03.018 – volume: 53 start-page: 21 year: 2016 ident: 10.1016/j.xops.2024.100525_bib36 article-title: Retinal stimulation strategies to restore vision: fundamentals and systems publication-title: Prog Retin Eye Res doi: 10.1016/j.preteyeres.2016.05.002 – volume: 57 start-page: 6147 year: 2016 ident: 10.1016/j.xops.2024.100525_bib35 article-title: One-year outcome of 49-channel suprachoroidal–transretinal stimulation prosthesis in patients with advanced retinitis pigmentosa publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.16-20367 – volume: 9 start-page: 31 year: 2020 ident: 10.1016/j.xops.2024.100525_bib40 article-title: Oculomotor responses to dynamic stimuli in a 44-channel suprachoroidal retinal prosthesis publication-title: Transl Vis Sci Technol doi: 10.1167/tvst.9.13.31 – volume: 15 year: 2020 ident: 10.1016/j.xops.2024.100525_bib33 article-title: PRIMA subretinal wireless photovoltaic microchip implantation in non-human primate and feline models publication-title: PLoS One doi: 10.1371/journal.pone.0230713 – volume: 254 start-page: 947 year: 2016 ident: 10.1016/j.xops.2024.100525_bib42 article-title: False reaching movements in localization test and effect of auditory feedback in simulated ultra-low vision subjects and patients with retinitis pigmentosa publication-title: Graefes Arch Clin Exp Ophthalmol doi: 10.1007/s00417-015-3253-2 – volume: 55 start-page: 1834 year: 2014 ident: 10.1016/j.xops.2024.100525_bib43 article-title: The use of Argus® II retinal prosthesis to identify common objects in blind subjects with outer retinal dystrophies publication-title: Invest Ophthalmol Vis Sci – volume: 63 start-page: 107 year: 2018 ident: 10.1016/j.xops.2024.100525_bib1 article-title: Molecular genetics and emerging therapies for retinitis pigmentosa: basic research and clinical perspectives publication-title: Prog Retin Eye Res doi: 10.1016/j.preteyeres.2017.10.004 – year: 2022 ident: 10.1016/j.xops.2024.100525_bib9 article-title: A new high-resolution three-dimensional retinal implant: system design and preliminary human results publication-title: bioRxiv – volume: 36 start-page: 1 year: 2013 ident: 10.1016/j.xops.2024.100525_bib20 article-title: The Argus™ II retinal prosthesis: factors affecting patient selection for implantation publication-title: Prog Retin Eye Res doi: 10.1016/j.preteyeres.2013.01.002 – volume: 89 start-page: 9666 year: 1992 ident: 10.1016/j.xops.2024.100525_bib14 article-title: Dendritic field size and morphology of midget and parasol ganglion cells of the human retina publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.89.20.9666 – volume: 9 start-page: 25 year: 2020 ident: 10.1016/j.xops.2024.100525_bib19 article-title: Harmonization of outcomes and vision endpoints in vision restoration trials: recommendations from the international HOVER taskforce publication-title: Transl Vis Sci Technol doi: 10.1167/tvst.9.8.25 – volume: 16 start-page: 606 year: 2001 ident: 10.1016/j.xops.2024.100525_bib26 article-title: The PHQ-9: validity of a brief depression severity measure publication-title: J Gen Intern Med doi: 10.1046/j.1525-1497.2001.016009606.x – volume: 55 start-page: 8458 year: 2014 ident: 10.1016/j.xops.2024.100525_bib23 article-title: Developing an instrumental activities of daily living tool as part of the low vision assessment of daily activities protocol publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.14-14732 – volume: 143 start-page: 820 year: 2007 ident: 10.1016/j.xops.2024.100525_bib4 article-title: Visual performance using a retinal prosthesis in three subjects with retinitis pigmentosa publication-title: Am J Ophthalmol doi: 10.1016/j.ajo.2007.01.027 – volume: 99 start-page: 227 year: 2016 ident: 10.1016/j.xops.2024.100525_bib46 article-title: An analysis of observer-rated functional vision in patients implanted with the Argus II Retinal Prosthesis System at three years publication-title: Clin Exp Optom doi: 10.1111/cxo.12359 – volume: 14 start-page: 310 year: 2021 ident: 10.1016/j.xops.2024.100525_bib3 article-title: Safety, effectiveness, and cost-effectiveness of Argus II in patients with retinitis pigmentosa: a systematic review publication-title: Int J Ophthalmol-Chi doi: 10.18240/ijo.2021.02.20 – volume: 9 year: 2014 ident: 10.1016/j.xops.2024.100525_bib10 article-title: First-in-human trial of a novel suprachoroidal retinal prosthesis publication-title: PLoS One doi: 10.1371/journal.pone.0115239 – volume: 98 start-page: 342 year: 2015 ident: 10.1016/j.xops.2024.100525_bib24 article-title: FLORA™: phase I development of a functional vision assessment for prosthetic vision users publication-title: Clin Exp Optom doi: 10.1111/cxo.12242 – volume: 10 start-page: 12 year: 2021 ident: 10.1016/j.xops.2024.100525_bib11 article-title: A second-generation (44-channel) suprachoroidal retinal prosthesis: interim clinical trial results publication-title: Transl Vis Sci Technol doi: 10.1167/tvst.10.10.12 – volume: 58 start-page: 3231 year: 2017 ident: 10.1016/j.xops.2024.100525_bib21 article-title: Determining the contribution of retinotopic discrimination to localization performance with a suprachoroidal retinal prosthesis publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.16-21041 – volume: 10 year: 2015 ident: 10.1016/j.xops.2024.100525_bib45 article-title: Visual and non-visual navigation in blind patients with a retinal prosthesis publication-title: PLoS One doi: 10.1371/journal.pone.0134369 – volume: 125 start-page: 432 year: 2018 ident: 10.1016/j.xops.2024.100525_bib5 article-title: Assessment of the electronic retinal implant Alpha AMS in restoring vision to blind patients with end-stage retinitis pigmentosa publication-title: Ophthalmology doi: 10.1016/j.ophtha.2017.09.019 – volume: 6 start-page: 65 year: 1979 ident: 10.1016/j.xops.2024.100525_bib30 article-title: A simple sequentially rejective multiple test procedure publication-title: Scand J Stat – volume: 12 start-page: 20 year: 2023 ident: 10.1016/j.xops.2024.100525_bib41 article-title: Estimating phosphene locations using eye movements of suprachoroidal retinal prosthesis users publication-title: Transl Vis Sci Technol doi: 10.1167/tvst.12.3.20 – volume: 49 start-page: 418 year: 2021 ident: 10.1016/j.xops.2024.100525_bib8 article-title: Retinal prostheses: where to from here? publication-title: Clin Exp Ophthalmol doi: 10.1111/ceo.13950 – volume: 51 start-page: 1255 year: 2010 ident: 10.1016/j.xops.2024.100525_bib22 article-title: Basic quantitative assessment of visual performance in patients with Very low vision publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.09-3512 – year: 1998 ident: 10.1016/j.xops.2024.100525_bib29 – volume: 11 start-page: 12 year: 2022 ident: 10.1016/j.xops.2024.100525_bib31 article-title: A second-generation (44-channel) suprachoroidal retinal prosthesis: long-term observation of the electrode–tissue interface publication-title: Transl Vis Sci Technol doi: 10.1167/tvst.11.6.12 – volume: 123 start-page: 2248 year: 2016 ident: 10.1016/j.xops.2024.100525_bib44 article-title: Five-year safety and performance results from the Argus II retinal prosthesis system clinical trial publication-title: Ophthalmology doi: 10.1016/j.ophtha.2016.06.049 – volume: 13 start-page: 15 year: 2016 ident: 10.1016/j.xops.2024.100525_bib15 article-title: Vision function testing for a suprachoroidal retinal prosthesis: effects of image filtering publication-title: J Neural Eng doi: 10.1088/1741-2560/13/3/036013 – volume: 46 start-page: 4007 year: 2005 ident: 10.1016/j.xops.2024.100525_bib49 article-title: Vision and quality of life: the development of a utility measure publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.04-1389 – volume: 83 start-page: 1163 year: 1988 ident: 10.1016/j.xops.2024.100525_bib28 article-title: Friedman-type statistics and consistent multiple comparisons for unbalanced designs with missing data publication-title: J Am Stat Assoc doi: 10.1080/01621459.1988.10478715 – volume: 95 start-page: 539 year: 2011 ident: 10.1016/j.xops.2024.100525_bib38 article-title: Blind subjects implanted with the Argus II retinal prosthesis are able to improve performance in a spatial-motor task publication-title: Br J Ophthalmol doi: 10.1136/bjo.2010.179622 – volume: 131 start-page: 183 year: 2013 ident: 10.1016/j.xops.2024.100525_bib39 article-title: The detection of motion by blind subjects with the epiretinal 60-electrode (Argus II) retinal prosthesis publication-title: JAMA Ophthalmol doi: 10.1001/2013.jamaophthalmol.221 – volume: 11 start-page: 4 year: 2022 ident: 10.1016/j.xops.2024.100525_bib27 article-title: Interobserver agreement of electrode to retina distance measurements in a second-generation (44-channel) suprachoroidal retinal prosthesis publication-title: Transl Vis Sci Technol doi: 10.1167/tvst.11.9.4 – volume: 58 start-page: 4204 year: 2017 ident: 10.1016/j.xops.2024.100525_bib16 article-title: A pre-clinical model for safe retinal stimulation publication-title: Invest Ophthalmol Vis Sci – volume: 137 start-page: 896 year: 2019 ident: 10.1016/j.xops.2024.100525_bib34 article-title: One-year safety and performance assessment of the Argus II retinal prosthesis: a postapproval study publication-title: JAMA Ophthalmol doi: 10.1001/jamaophthalmol.2019.1476 |
| SSID | ssj0002513241 |
| Score | 2.3238618 |
| Snippet | To assess the feasibility of a second-generation (44-channel) suprachoroidal retinal prosthesis for provision of functional vision in recipients with end-stage... PurposeTo assess the feasibility of a second-generation (44-channel) suprachoroidal retinal prosthesis for provision of functional vision in recipients with... Purpose: To assess the feasibility of a second-generation (44-channel) suprachoroidal retinal prosthesis for provision of functional vision in recipients with... |
| SourceID | doaj pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 100525 |
| SubjectTerms | Activities of daily living Bionic eye Functional vision Ophthalmology Original Retinitis pigmentosa Suprachoroidal retinal prosthesis |
| Title | A Second-Generation (44-Channel) Suprachoroidal Retinal Prosthesis: A Single-Arm Clinical Trial of Feasibility |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S2666914524000617 https://www.clinicalkey.es/playcontent/1-s2.0-S2666914524000617 https://dx.doi.org/10.1016/j.xops.2024.100525 https://www.ncbi.nlm.nih.gov/pubmed/39328823 https://www.proquest.com/docview/3110403832 https://pubmed.ncbi.nlm.nih.gov/PMC11426041 https://doaj.org/article/3a20a1a10d28475b9c47d7d3672f0e3e |
| Volume | 5 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3daxQxEA_SB_FF_HbVlgg-KBLM5mM_-tYWSxEq4rXQt5BNstzJsVu6d6D_vTOb7HGn0r74dHC3yR4zszO_2cz8hpB3GkIUb_OGYexiyhYts0J65myl66AhZIwn-Odfi7NL9eVKX22N-sKasEgPHAX3SVrBbW5z7tGR6qZ2qvSll0UpWh5kQO8LMW8rmUIfDFEbkEKeumRiQdfP_hr5uYXCygCNs7G3ItFI2L8TkP4GnH_WTW4FotNH5GFCkPQo_vPH5F7onpD75-mM_CnpjugMs1zPIqU0Sp6-V4phI0EXlh_obI29UfP-pl942Ok7dj3D5zdsAJmHYTEcUtgDYtoyMDAEmrhDl_QCrZX2LQXgmMpqfz0jl6efL07OWJqqwFwhqhWrpOS81Y1DskGvrKuLvFFt3TjIV7nHh7hyQntdKuWKMjStrhrVVLbVAcyOy-dkr-u78JJQZMOztbfCCa4U5D6Qu7lWuFDbCnSmMpJPEjYuUY7j5IulmWrLfhjUikGtmKiVjHzcrLmOhBu3Xn2MittciWTZ4xdgQiaZkLnLhDIiJ7WbqR8VPChstLj11uW_VoUhOYHB5GYQhpsZYKCizpXGcl1EjBnRm5UJ50T8cucd3042acAJ4MmO7UK_HowEEKe4BO-ckRfRRjcikYDQIY2SGal2rHdHZru_dIv5SDSOfdYFV_mr_yHl1-SBwNnJ4-urN2RvdbMO-wDoVs3B-OwejG_afgOszEeL |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Second-Generation+%2844-Channel%29+Suprachoroidal+Retinal+Prosthesis%3A+A+Single-Arm+Clinical+Trial+of+Feasibility&rft.jtitle=Ophthalmology+science+%28Online%29&rft.au=Petoe%2C+Matthew+A.&rft.au=Abbott%2C+Carla+J.&rft.au=Titchener%2C+Samuel+A.&rft.au=Kolic%2C+Maria&rft.date=2025-01-01&rft.pub=Elsevier+Inc&rft.issn=2666-9145&rft.eissn=2666-9145&rft.volume=5&rft.issue=1&rft_id=info:doi/10.1016%2Fj.xops.2024.100525&rft.externalDocID=S2666914524000617 |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F26669145%2FS2666914524X00020%2Fcov150h.gif |